ReviewBiochim Biophys Acta Rev Cancer2020
Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
- Journal
- Biochim Biophys Acta Rev Cancer
- Published
- 30 October 2019
- Citations
- 45
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 8
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Targeting Mucin and EGFR Axis in Pancreatic Cancer R01CA183459↗
- Rac1 GTPase in tumorigenesis and progression of pancreatic cancer R01CA206444↗
- Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia R01CA210637↗
- Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer R44CA224619↗
- MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases R44DK117472↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗
- Pancreatic Cancer Detection Consortium U01CA210240↗